Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Grove Collaborative Holdings, Inc. Class A Common Stock (NY:GROV)

1.380 -0.020 (-1.43%)
Official Closing Price Updated: 7:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Grove Collaborative Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
A Preview Of Grove Collaborative Hldgs's Earnings
 
Via Benzinga
Grove to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
From Grove Collaborative Holdings, Inc.
Via Business Wire
Grove Collaborative Appoints Scott Giesler as General Counsel
From Grove Collaborative Holdings, Inc.
Via Business Wire
Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships
From Grove Collaborative Holdings, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
5 Value Stocks To Watch In The Consumer Defensive Sector
 
Via Benzinga
Recap: Grove Collaborative Hldgs Q3 Earnings
 
Via Benzinga
Grove Announces Fiscal Third Quarter 2023 Financial Results
From Grove Collaborative Holdings, Inc.
Via Business Wire
Grove to Report Third Quarter 2023 Financial Results on November 9, 2023
From Grove Collaborative Holdings, Inc.
Via Business Wire
5 Value Stocks To Watch In The Consumer Defensive Sector
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
10 Consumer Discretionary Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
 
Via Benzinga
5 Value Stocks In The Consumer Defensive Sector
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
5 Value Stocks To Watch In The Consumer Defensive Sector
 
Via Benzinga
Overview Of Value Stocks In The Consumer Defensive Sector
 
Via Benzinga
5 Value Stocks In The Consumer Defensive Sector
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
10 Short Squeeze Stocks To Watch: Blue Apron, Getty Images, Black Rifle Coffee And More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
A Look Into Consumer Defensive Sector Value Stocks
 
Via Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Blue Apron, T Stamp, Black Rifle Coffee And More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
These Are the ONLY 7 Penny Stocks to Consider in August 2023
These are just a few of the most promising penny stocks to consider as we head into the final months of the year. 
Via InvestorPlace
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
 
Via Benzinga
11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback